glp-1 weight loss drug market news today new Harvard-led study suggests women taking weight-loss medications like Ozempic and Wegovy may have an advantage in the job market. Researchers found that unemployed women using GLP-1 medications were 27% The current range of weight-loss
Description
Strong clinical evidence demonstrating sustained weight loss and cardiometabolic benefits is boosting confidence among patients and healthcare providers
De Prisco, C
Large randomized trials consistently show robust weight-loss efficacy
According to Eurostat, the proportion of people aged 65 and older in the EU is predicted to increase from 20% in 2020 to approximately 30% by 2050
Adverse events such as increased blood calcitonin, goiter and thyroid tumor may occur
